COR - Cencora, Inc.

Dashboard

Manage Tickers Link Financial Account

CORCencora, Inc.

NYSE www.cencora.com

$ 235.05 $ -1.27 (-0.54 %)

Friday, 06-Sep-2024 15:59:59 EDT

CLICK TO SEE RELEVANT LITIGATION UPDATES

Y-mAbs Therapeutics, Inc. | YMAB | Take Action!

QQQ $ 446.25 $ -12.35 (-2.68 %)

DIA $ 404.28 $ -3.99 (-0.98 %)

SPY $ 539.90 $ -9.25 (-1.68 %)

TLT $ 99.49 $ -0.01 (-0.01 %)

GLD $ 230.65 $ -1.72 (-0.74 %)

Previous Close

$ 234.97

Open

Bid

$ 235.20 x 179

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 170.83 - $ 247.13

Volume

1,831,577

Average Volume

na

Market Cap

46.3B

Beta (5Y Monthly)

$ 0.62

PE Ratio (TTM)

$ 24.94

EPS (TTM)

TBD

Earnings Date

na

Dividend & Yield

na ($ 0.01)

Last Ex-Dividend

na

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
1	07-31-2024	06-30-2024	10-Q
2	05-01-2024	03-31-2024	10-Q
3	01-31-2024	12-31-2023	10-Q
4	11-21-2023	09-30-2023	10-K
5	08-02-2023	06-30-2023	10-Q
6	05-02-2023	03-31-2023	10-Q
7	02-01-2023	12-31-2022	10-Q
8	11-22-2022	09-30-2022	10-K
9	08-03-2022	06-30-2022	10-Q
10	05-04-2022	03-31-2022	10-Q
11	02-02-2022	12-31-2021	10-Q
12	11-23-2021	09-30-2021	10-K
13	08-04-2021	06-30-2021	10-Q
14	05-05-2021	03-31-2021	10-Q
15	02-04-2021	12-31-2020	10-Q
16	11-19-2020	09-30-2020	10-K
17	08-05-2020	06-30-2020	10-Q
18	05-07-2020	03-31-2020	10-Q
19	01-30-2020	12-31-2019	10-Q
20	11-19-2019	09-30-2019	10-K
21	08-01-2019	06-30-2019	10-Q
22	05-02-2019	03-31-2019	10-Q
23	01-31-2019	12-31-2018	10-Q
24	11-20-2018	09-30-2018	10-K
25	08-02-2018	06-30-2018	10-Q
26	05-02-2018	03-31-2018	10-Q
27	02-06-2018	12-31-2017	10-Q
28	11-21-2017	09-30-2017	10-K
29	08-03-2017	06-30-2017	10-Q
30	05-04-2017	03-31-2017	10-Q
31	01-31-2017	12-31-2016	10-Q
32	11-22-2016	09-30-2016	10-K
33	08-02-2016	06-30-2016	10-Q
34	05-05-2016	03-31-2016	10-Q
35	02-04-2016	12-31-2015	10-Q
36	11-24-2015	09-30-2015	10-K
37	08-06-2015	06-30-2015	10-Q
38	05-08-2015	03-31-2015	10-Q
39	02-06-2015	12-31-2014	10-Q
40	11-25-2014	09-30-2014	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

deep-dive-into-cencora-stock-analyst-perspectives-6-ratings

Deep Dive Into Cencora Stock: Analyst Pers...
09/06/2024 13:00:57

Baird Maintains Outperform on Cencora, Low...
09/06/2024 11:07:10

Baird analyst David Rodgers maintains Cencora (NYSE:COR) with a Outperform and lowers the price target from $287 to $283.

opioid-settlement-drug-distributors-mckesson-cencora-cardinal-health-to-pay-300m-to-health-insurers

Opioid Settlement: Drug Distributors McKes...
09/03/2024 19:14:34

Three major U.S. drug distributors, McKesson, Cencora, and Cardinal Health, have agreed to a $300 million settlement over claim...

1000-invested-in-cencora-5-years-ago-would-be-worth-this-much-today

$1000 Invested In Cencora 5 Years Ago Woul...
08/28/2024 20:00:48

Core News & Articles

Watching Cencora; Traders Circulate Unconf...
08/26/2024 15:00:18

deep-dive-into-cencora-stock-analyst-perspectives-5-ratings

Deep Dive Into Cencora Stock: Analyst Pers...
08/21/2024 15:00:27

JP Morgan Maintains Overweight on Cencora,...
08/21/2024 14:08:22

JP Morgan analyst Lisa Gill maintains Cencora (NYSE:COR) with a Overweight and raises the price target from $280 to $287.

peering-into-cencoras-recent-short-interest

Peering Into Cencora's Recent Short Interest
08/14/2024 14:30:14

heres-how-much-you-would-have-made-owning-cencora-stock-in-the-last-5-years

Here's How Much You Would Have Made Owning...
08/02/2024 14:00:39

Core News & Articles

Cencora Announces $250M Common Share Repur...
08/01/2024 22:23:06

Cencora, Inc. (NYSE:COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Allia...

Core News & Articles

Walgreens Boots Alliance Sells All Remain...
08/01/2024 22:22:38

Transaction HighlightsWalgreens Boots Alliance announces sale of all remaining unencumbered shares of Cencora, Inc. for proceed...

Wells Fargo Maintains Equal-Weight on Cenc...
08/01/2024 13:43:31

Wells Fargo analyst Stephen Baxter maintains Cencora (NYSE:COR) with a Equal-Weight and raises the price target from $236 to...

Baird Maintains Outperform on Cencora, Rai...
08/01/2024 11:54:12

Baird analyst David Rodgers maintains Cencora (NYSE:COR) with a Outperform and raises the price target from $285 to $287.

Cencora Forecasts 2024 Adjusted EPS Of $13...
07/31/2024 10:34:39

Cencora Q3 2024 Adjusted EPS $3.34 Beats $...
07/31/2024 10:33:08

10-health-care-stocks-whale-activity-in-todays-session

10 Health Care Stocks Whale Activity In To...
07/30/2024 17:35:22

if-you-invested-100-in-this-stock-5-years-ago-you-would-have-300-today

If You Invested $100 In This Stock 5 Years...
07/17/2024 20:00:21

abbvie-appeals-to-supreme-court-over-attorney-client-privilege-in-long-standing-androgel-case

AbbVie Appeals To Supreme Court Over Attor...
07/12/2024 17:39:05

AbbVie petitions the U.S. Supreme Court to protect its corporate records, arguing a lower court ruling threatens attorney-clien...

if-you-invested-100-in-this-stock-5-years-ago-you-would-have-200-today

If You Invested $100 In This Stock 5 Years...
07/09/2024 18:30:34

a-closer-look-at-4-analyst-recommendations-for-cencora

A Closer Look at 4 Analyst Recommendations...
07/09/2024 13:00:29

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION